Podcasts about Toga

Welcome to Episode 80  of the Wed.Co Podcast. Today, Toga sits down with Mel from MJ Vegan MUA for a chat about her growth mindset and how everything changes in her Wedding Business. In this episode, Mel shares her inspiring journey from starting her makeup business while working in real estate, to building a successful, sustainable brand that prioritizes efficiency, client experience, and personal values. She discusses the pivotal moments that shifted her business mindset, from embracing systems to rebranding her website, and managing her time as a busy single mom. Key Topics: Mel's early struggles balancing a growing wedding makeup business with family life The impact of COVID on her business and lessons learned Transitioning from scattered systems to streamlined workflows with Studio Ninja Rebranding her website to attract commercial and e-commerce clients Simplifying client communication and admin with automation The importance of leveraging system tools to save up to 30 hours per wedding Strategies for raising prices confidently through consistent booking Building a personal brand that reflects her fun, professional personality Expanding her team with an efficient hair stylist to handle larger bookings Recognizing the value of operating as a vegan-focused, niche provider The mindset shift from emergency mode to sustainable growth The importance of speed in business decisions and implementation Growth plans for 2026 and beyond, with a goal of more stability and less reliance on agencies Advice for fellow entrepreneurs: embracing systems, taking bold action quickly, and prioritizing time over everything If you want to hear more from Mel you can get more info at ⁠https://www.mjvegan.com⁠ and on Instagram at ⁠https://www.instagram.com/mj.veganmua/⁠ Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals.   Stay connected with us on Instagram at ⁠https://www.instagram.com/wed.copodcast⁠ and watch all your favorite wedding professionals on our YouTube channel ⁠https://www.youtube.com/@Wed.CoPodcast⁠ Catch our episodes on major podcast platforms like ⁠Apple⁠, ⁠Spotify⁠, and ⁠Youtube,⁠ all under WedCo Podcast.   For all of your Wedding Photography / Videography needs head over to ⁠https://www.instagram.com/the_tognazzinis/⁠ or our website at ⁠https://thetognazzinis.com.au/⁠ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the  mesmerising and ever-changing landscape of weddings.   Toga    

Shot of Nostalgia: Shuffle continues with your host Acefield Retro, and this week we revisit April 4, 1993, WrestleMania IX from Caesars Palace in Paradise, Nevada. The first fully outdoor WrestleMania. The World's Largest Toga Party. A Roman coliseum theme complete with live animals, trumpeters, and commentators fully committed to the presentation. But beyond the spectacle, this event represents a pivot. This episode traces the road into WrestleMania IX through the March and April 1993 Wrestling Observer Newsletter coverage, capturing a company navigating lawsuits, scrutiny, roster instability, and mounting pressure. Bret Hart entered as WWF Champion. Yokozuna had been elevated as the dominant Royal Rumble winner. Hulk Hogan had returned, but his long term direction was fluid rather than locked in. The structure of the card reflects that instability. Shawn Michaels versus Tatanka opens with an Intercontinental Championship match that creates movement without definitive closure, immediately signaling protection over payoff. The Steiner Brothers versus the Headshrinkers provide one of the night's most cohesive in ring performances, reinforcing how effective the tag division could be when execution was clean. Doink versus Crush leans heavily into character psychology and spectacle, highlighted by the double Doink finish. We examine the originally planned mechanical stunt that was scrapped and what that decision says about the era's emphasis on visual moments. Razor Ramon secures a direct win over Bob Backlund, continuing his steady rise. The Tag Team Championship match between Money Inc. and the Mega Maniacs unfolds through referee bumps, disqualification tension, and spectacle driven pacing. We revisit the reported late reshuffling that removed the originally planned tag title blow off and centered Hogan more prominently on the card. Lex Luger's WrestleMania debut against Mr. Perfect introduces rope leverage controversy and is layered with behind the scenes anecdotes that contribute to the uneven rhythm of the night. The Undertaker versus Giant Gonzalez becomes one of the most criticized finishes in WrestleMania history, prioritizing theatricality over decisive resolution. The championship picture ultimately defines the event. Bret Hart versus Yokozuna is framed as a generational collision until Mr. Fuji's salt interference shifts the WWF Championship. Moments later, Hulk Hogan enters, accepts an impromptu challenge, and captures the title in approximately twenty seconds. With three decades of hindsight, this episode examines whether that closing decision reflects creative confusion or calculated business pragmatism. The Observer context suggests urgency. The optics suggest an audible. The result reshaped Bret Hart's reign, altered Yokozuna's trajectory, and placed Hogan back on top during a volatile moment for the company. WrestleMania IX is remembered for its ending. It deserves to be studied for what it reveals about transition, pressure, and how quickly direction can change when stability becomes the priority. Shot of Nostalgia: Shuffle premieres Saturday wherever you listen. Like, subscribe, and leave a review to support the continued growth of the series. Visit TurnbuckleTavern.com for merchandise, archives, and the full network schedule. Support the project at Patreon.com/TheTurnbuckleTavern for exclusive content and extended deep dives. Powered by G FUEL and Dick Lazers. Use code TAVERN at checkout to save twenty percent on your entire order.  

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic gastroesophageal cancer. They share first-line and subsequent-line recommendations for both gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma based on actionable biomarkers including PD-L1 expression, MMR and/or MSI, CLDN18.2 expression, and HER2 status. They note the importance of the algorithms and tables in the guidelines that provide visual illustrations and quick reference guides of the evidence-based recommendations. They also comment on ongoing and recently presented trials that may impact future guidelines in this space. Read the full guideline, "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update" at www.asco.org/gastrointestinal-cancer-guidelines" TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/gastrointestinal-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02958      Timestamps ·       00:00 – 02:15 Introduction and Overview ·       02:16 - 08:20 First-line treatment for patients with pMMR/MSS, HER2-negative gastroesophageal adenocarcinoma ·       08:21 –10:29 First-line treatment for patients with pMMR/MSS, HER2-positive gastroesophageal adenocarcinoma ·       10:30 – 14:39 First-line treatment for patients with dMMR/MSI-H, gastroesophageal adenocarcinoma ·       14:40 – 18:03 First-line treatment for ESCC ·       18:04 – 22:04 Second- and third-line therapy for gastroesophageal adenocarcinoma and ESCC ·       22:05 – 24:38 Importance of guideline ·       24:39 – 27:45 Outstanding questions and future research   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.   My name is Brittany Harvey, and today I am interviewing Dr. Lakshmi Rajdev from the Icahn School of Medicine at Mount Sinai and Dr. Manish Shah from Weill Cornell Medicine, co-chairs on "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update." Thank you for being here today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you for having us. It is wonderful. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Rajdev and Dr. Shah, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into what we are here today to talk about, Dr. Shah, I would like to start first with what prompted the update to this guideline, which was previously published in 2023, and what is the scope of this updated guideline? Dr. Manish Shah: Yes, terrific. So even in the last few years, the pace of drug development in gastroesophageal cancers has just been astounding. So, what prompted this guideline is actually the practice-changing results for a new biomarker, CLDN18.2 hat was based on the GLOW and SPOTLIGHT studies, as well as a practice-changing study in HER2-positive disease where we added pembrolizumab to trastuzumab and chemotherapy for tumors that are HER2-positive and PD-L1 CPS 1 or greater. And then there were also new studies and new approvals in esophageal squamous cell cancer that you will hear about as well. So there were several studies, overall more than 5,000 patients were reported on, and that led to several new therapies, new indications, and it really necessitated this guideline. Brittany Harvey: Excellent. It is great to hear about all of these exciting updates in this space. So then to next review the key recommendations of this guideline by clinical question that the expert panel addressed. So, Dr. Rajdev, what is the recommended first-line treatment for patients with proficient mismatch repair, microsatellite stable, HER2-negative gastroesophageal adenocarcinoma? Dr. Lakshmi Rajdev: Thank you for that question. So historically, we have sort of used fluoropyrimidine and platinum doublets, which yielded a survival of about one year. More recently, immunotherapy and targeted therapy options have improved outcomes in patients with advanced esophageal and gastric adenocarcinoma, as well as squamous cell carcinoma. Patients with gastric and GE junction adenocarcinoma have a high rate of actionable alterations, so it is imperative that physicians test the following biomarkers upfront so that it can help guide therapy. The markers recommended by the ASCO panel are HER2, MMR or MSI, CLDN18.2, and PD-L1. And also, it was recommended to use NGS if feasible in this patient population. HER2, as we know, is expressed in about 15% to 25% of patients; PD-L1 expression occurs in about 80% of patients; MSI-high, deficient MMR is present in about 5% to 8% of patients; and CLDN18.2 expression is present in about 40% of patients. There is, of course, biomarker overlap. About 13% to 22% of CLDN18.2 patients are also PD-L1 positive. For patients with pMMR or microsatellite stable HER2-negative disease with PD-L1 expression greater than 1 and absence of CLDN18.2, the panel recommended a first-line therapy with fluoropyrimidine and platinum-based therapy in combination with immunotherapy. These recommendations stem from large phase 3 trials, and the agents approved in the United States are pembrolizumab, nivolumab, and tislelizumab. It has been shown that immunotherapy benefit is greater in patients with higher PD-L1 expression, and it is not possible to comment on the individual PD-L1 cutoff scores and sort of identify the optimal PD-L1 cutoff score that sort of balances benefits and harms. But what is recommended is that immunotherapy-based treatments can be offered in patients with a CPS score of greater than 1. With regard to the choice of immunotherapy agents, that is pembrolizumab, nivolumab, or tislelizumab, these agents are considered to have similar efficacy, and the selection of an agent could be based on dosing schedule, cost considerations, toxicity, and the method of administration. Typically, clinicians should avoid withholding the start of chemotherapy while awaiting biomarker testing, depending on the clinical scenario. Now, for patients with pMMR microsatellite stable disease that is HER2-negative with PD-L1 expression less than 1 and positive CLDN18.2 expression, zolbetuximab-based treatments or in combination with chemotherapy is recommended, and this is based on two global phase III randomized controlled trials, the GLOW and the SPOTLIGHT. And across both studies, the hazard ratio for the overall survival was 0.78, and similarly, there was also an improvement in progression-free survival favoring the zolbetuximab group compared to the chemotherapy group alone. An important note is that nausea, vomiting is commonly associated with zolbetuximab-based treatments, and the panel recommended prophylactic antiemetics, adjusting zolbetuximab infusion rates, pausing infusion temporarily, using non-prophylactic antiemetics, and hydration intravenously prior to discontinuation of zolbetuximab-based chemotherapy. So effective handling of the GI-related symptoms with zolbetuximab is recommended prior to discontinuation of therapy. Now, for patients with pMMR microsatellite stable HER2-negative gastric, GE junction adenocarcinoma with PD-L1 expression greater than 1 and CLDN18.2 positivity, the ones with the dual expression with CLDN18.2 as well as PD-L1 chemotherapy, the choice of therapy can be based on the degree of PD-L1 expression, the toxicity profile, the burden of symptoms, and the anticipated improvement in symptoms associated with response to treatment, the patient comorbidities, the prior medical and treatment history. So this decision needs to be made on a case-by-case basis, and these are some of the factors that we suggested that could potentially influence the choice of therapy. For patients with pMMR microsatellite stable disease that is HER2-negative and a PD-L1 expression less than 1 and an absence of CLDN18.2 expression, first-line therapy with fluoropyrimidine and platinum-based chemotherapy is recommended. So you can see we have segmented out patients based on PD-L1 expression, pMMR and microsatellite stable disease expression, and also based on CLDN expression. Brittany Harvey: Absolutely. And that first point you noted, I think is really important, that biomarker testing is really critical for treatment decision-making in this space. So then the next subgroup of patients that the panel looked at, Dr. Shah, what first-line therapy is recommended for patients with proficient mismatch repair, microsatellite stable, HER2-positive gastroesophageal adenocarcinoma? Dr. Manish Shah: So this was an update from a few years ago. So we have known for 15 years now that if you are HER2-positive, you should get trastuzumab plus chemotherapy. That was based on the ToGA trial. And the update now is based on a trial called KEYNOTE-811, where it examined the addition of pembrolizumab to trastuzumab and chemotherapy versus trastuzumab and chemotherapy, and there was a progression-free and overall survival benefit. And again, here, the biomarkers are important. If your CPS PD-L1 is less than 1, we would not recommend Pembrolizumab in that setting, so you would still get trastuzumab and chemotherapy. But if it is 1 or greater, the PD-L1 CPS score, then we do recommend pembrolizumab unless there is a contraindication to immunotherapy. The take-home message really is from the onset of diagnosis, please check your biomarkers. And I will just, it is worth repeating, it is important to check your PD-L1 status, HER2 status, mismatch repair status, and CLDN18.2 status. And then the optimal therapy, and it is outlined in the publication, is really biomarker-driven. We know that if we are able to hit the target that is overexpressed, we are going to have a better outcome. And Dr. Rajdev did mention where there is overlap, there can be a lack of data, and that is where we are with both PD-L1 positive and CLDN positive. Here we do have data in HER2-positive cases where if you are both HER2-positive and PD-L1 positive, you would combine trastuzumab and pembrolizumab for the best outcomes. Brittany Harvey: Understood. I really appreciate you detailing what is most important for each individual biomarker combination that patients may have. So then following that, Dr. Rajdev, what does the expert panel recommend for first-line treatment for patients with esophageal squamous cell carcinoma that is not amenable to definitive chemoradiation? Dr. Lakshmi Rajdev: There are three phase III randomized clinical trials that have influenced practice in patients with esophageal squamous cell carcinoma examining the benefit of immunotherapy in this patient population. The RATIONALE-306 was a randomized trial of tislelizumab plus chemotherapy with platinum and fluoropyrimidine or paclitaxel versus placebo with chemotherapy. And then you have the KEYNOTE-590, which compared pembrolizumab plus chemotherapy versus chemotherapy alone. And then you have CheckMate-648, which included comparisons of nivolumab plus chemotherapy versus nivolumab plus ipilimumab or chemotherapy. And the primary endpoints for these studies were overall survival, and they did look at subgroups with PD-L1 expression. They used TPS score greater than 1% in CheckMate-648 and PD-L1 CPS greater than 10 in KEYNOTE-590. The bottom line is that the overall hazard ratio for overall survival across this patient population was 0.72. So clearly, there is benefit in patients that express PD-L1 CPS greater than 1 for benefit for the addition of immunotherapy. Now, the benefit again in patients with a PD-L1 expression less than 1 remains limited, and so the panel has made a recommendation for using immunotherapy in combination with platinum-based chemotherapy in patients with a PD-L1 greater than 1. Again, we know that it is hard to make recommendations on what PD-L1 cutoffs are recommended in this patient population, meaning that should it be limited to patients with a PD-L1 of 1 to 4 or greater than 10? I think that the general consensus that has been gleaned from the data is that the higher the PD-L1 expression, the greater the benefit. I do want to comment on another option that is available in patients with squamous cell carcinoma compared to adenocarcinoma, and that is the combination of nivolumab and ipilimumab. Now, in CheckMate-648, nivolumab with ipilimumab was also recommended as a treatment option in patients that have a PD-L1 score of greater than 1. There was a survival benefit demonstrated with this combination compared to chemotherapy alone. And an important observation in this study is that, although there was a slightly increased rate in early death, but there was really no significant difference in PFS and OS compared to chemotherapy alone. Importantly, the treatment appeared to be pretty well tolerated by the study population. There was a notable difference in the objective response rate, which was 35% in the nivolumab plus ipilimumab group compared to patients receiving nivolumab and chemotherapy, where it was 53%. So superiority is, so the importance of chemotherapy in patients with esophageal squamous cell carcinoma is to be noted. However, there is no difference in overall survival and progression-free survival when using the combination of nivolumab and ipilimumab, and thus it affords a chemotherapy-free option for this patient population with esophageal squamous cell carcinoma and a CPS with a score of greater than 1. Brittany Harvey: Understood. I appreciate you reviewing the evidence underpinning those recommendations as well. So then the next patient population that the guideline panel addressed, what first-line therapy is recommended for patients with deficient mismatch repair, microsatellite instability-high, gastroesophageal adenocarcinoma or esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: The rate of MSI-high expression is about 3% to 7% across different studies. Now, the KEYNOTE-158 was a tumor-agnostic study in patients with non-colorectal cancers, and again, the problem with the MSI-high population, given that it is so rare, the numbers in the individual studies are fairly small. But consistent outcomes do emerge, indicating high response to immunotherapy. So in KEYNOTE-158, a response rate of about 46% was noted. The number of patients was small, it was about 24. In CheckMate-649, which is a study of chemotherapy plus or minus nivolumab in patients with advanced gastric adenocarcinoma, there was again a very small number of patients, and patients that were MSI-high or deficient MMR did experience substantial benefits with the addition of immunotherapy, with hazard ratios in the order of about 0.38. In KEYNOTE-062, again, it was a very small number of patients, again about 6% or so, and similar to CheckMate-649, a substantial benefit was noted in combination with chemotherapy, but also there were benefits noted with pembrolizumab alone. The RATIONALE-305 again was a study of tislelizumab in combination with chemotherapy and similarly showed benefits to the combination of chemotherapy plus immunotherapy in this patient population. I think that we are all aware of the dramatic benefits of immunotherapy in this particular subset of patients, deficient MMR MSI-high, and also we have seen in CheckMate-649 they did have a subset of patients that received nivolumab and ipilimumab. And in this patient population, they noted unstratified hazard ratio of 0.28. So I think that the overall consensus is that immunotherapy is a very important treatment modality in patients with deficient MMR MSI-high disease, given that a lot of the trials in gastroesophageal adenocarcinoma have utilized chemotherapy-based options, that is certainly a recommendation of the panel to use chemotherapy in combination with immunotherapy. However, on a case-by-case basis, the panel recommended immunotherapy alone as well, and given the high response rates noted in trials across different diseases as well as noted in this disease as well. Brittany Harvey: Certainly. And I appreciate you both for reviewing these first-line recommendations. So moving to later lines of therapy, Dr. Rajdev, what recommendations did the expert panel make for second or third-line therapy for gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: So, I think that the RAINBOW trial that investigated the utility of the addition of ramucirumab as second-line therapy has been around since 2014, and those results have led to the addition of ramucirumab to taxane-based therapy in the second-line setting. Based on the utilization of oxaliplatin and platinum-based therapy in the front-line setting, there may be patients that have an underlying neuropathy, and so we wanted to really include treatment options for this patient population so that an agent that is less neurotoxic could also be recommended in combination with ramucirumab. The RAMIRIS trial is one such trial where ramucirumab was combined with FOLFIRI, and it demonstrated benefit in combination with ramucirumab. So we have listed that as a potential treatment option for patients in the second-line setting who may have an underlying neuropathy or even for whatever reason that based on the toxicity profile, that needs to be the preferred option by a physician, that recommendation is new from the older guidelines that we have. With regard to the utility of PD-1 inhibitors, there really has been no benefit noted in the second-line setting with regard to overall survival or progression-free survival, so no recommendation is made for that option. I think an important study that has been recently presented is the DESTINY-Gastric04 trial, which really has been practice-changing and has led to the recommendation for trastuzumab deruxtecan in patients that have HER2-positive metastatic gastric or GE junction adenocarcinoma. Now, this is a phase III trial in patients who retained HER2-positive disease after progressing on front-line trastuzumab-based treatments, and the comparator for this trial was trastuzumab deruxtecan versus ramucirumab plus paclitaxel. There was significant improvement and progression-free survival in patients that received trastuzumab deruxtecan. The patients that were excluded from the trial are patients that have pulmonary problems, interstitial lung disease; that is one of the toxicities of this particular agent, and close monitoring and prompt initiation of therapy such as glucocorticoid treatment in patients who develop this toxicity was also highlighted by the panel. So to summarize, the new guidelines highlight the possibility of FOLFIRI plus ramucirumab as a second-line option and then trastuzumab deruxtecan as a later-line option in patients that still retain HER2 expression. And that is very important because the trial did retest patients whether they expressed HER2. As we know, in a substantial number of patients, there is downregulation of HER2, and there is emerging data that the benefit for subsequent HER2-directed therapies is best noted in patients that still retain HER2 expression. Brittany Harvey: Great. So as our listeners have heard, there are many recommendations and new treatment options for advanced gastroesophageal cancer. Dr. Shah, earlier you highlighted the importance of biomarker testing, but I would like to hear in your view, what is the importance of this guideline and how will it impact both clinicians and patients with gastroesophageal carcinoma? Dr. Manish Shah: So as we have discussed throughout this podcast, the treatment for gastroesophageal cancer, both adenocarcinoma and squamous cell cancer, is increasingly complex, increasingly biomarker-driven. And I think the value of the guideline is to place all of that into context. So it provides the data for why certain biomarkers are important, what therapies should be indicated. Not only that, but if you are able to review the guideline, it provides the details of each of these studies and summarizes them in a meta-analysis fashion to sort of give you the context, because sometimes the individual studies can be maybe a little bit discordant or confusing and the guideline attempts to harmonize all that. And then also, I think the tables are very, very interesting because they give you actual numbers in terms of how many patients over a thousand would this benefit or how many patients over a thousand would this cause harm in terms of nausea, vomiting, or other things like that. So it gives you context for helping clinicians and patients weigh the potential benefits of the novel treatment strategies against the potential adverse events. And then finally, the guideline does also provide an algorithm that you are able to follow based on the biomarkers, and those are in figures 4 and 5. So I think overall, it is a very comprehensive guideline. It intends to make more manageable a very complex subject, and you know, I really encourage our listeners to review it after listening to the podcast. Dr. Lakshmi Rajdev: If I can add to that, I think that what is also really good about the guidelines is there are quick summaries. So if someone is busy in the clinic, of course, there is the opportunity to review the data supporting the guidelines in great depth in the manuscript, but what is also really good is that there are good summaries. In the event that you are very busy, you can easily identify what the recommendations should be for that particular patient based on these summaries. Brittany Harvey: Absolutely. Listeners are encouraged to review the full guideline, including those tables and figures that may be more helpful when they are looking for something quick to look at in the clinic as well. So, as you both mentioned, there have been a number of recent practice-changing trials in this area. So I imagine there is still a lot of ongoing research as well. So Dr. Shah, what are the outstanding questions regarding treatment options for patients with locally advanced unresectable, advanced, or metastatic gastroesophageal carcinoma? Dr. Manish Shah: I think we touched upon it a little bit. The guidelines are based on the data available, and they are primarily examining one novel therapy with chemotherapy in a specific biomarker population. But as you know, the biomarkers are not either/or; you are not either CLDN18.2 positive or PD-L1 positive. A portion of patients could have dual biomarkers, and you know, I think that we are generating data on how to manage those patients. At the recent GI Symposium in January this year, the ILUSTRO trial was presented by Dr. Shitara, which looked at combining zolbetuximab and chemotherapy with immunotherapy for dual-positive biomarkers, and that is leading to a phase III study that has begun to enroll. So unanswered questions are: how do we manage dual-positive biomarkers? The other thing that was mentioned is that the current data for mismatch repair deficiency involve chemotherapy plus immunotherapy. Only squamous cell cancer is there a study with a positive non-chemotherapy kind of backbone, that is CheckMate-648 that Dr. Rajdev mentioned. As we move forward, it will be good to get data on non-chemotherapy options in certain biomarker-positive populations. And then finally, another update, which is likely to be practice-changing, is the HERIZON-GEA-01 study that looked at zanidatamab, which is another biparatopic antibody that targets HER2, and that is likely to change practice. And as that data gets published, we may look to even do a rapid update for the current immunotherapy and targeted therapy guideline that is just being published. Dr. Lakshmi Rajdev: So, if I can add to that, there are numerous ADCs that look very interesting. There are bispecific antibodies; in fact, the zanidatamab is a bispecific antibody showing improved activity in patients with HER2-positive disease. So I think there are studies from Asia looking at CLDN CAR T-based therapies. So, I think that there are a lot of novel agents and a lot of excitement in the field. We know that the bemarituzumab study, unfortunately, the FGFR2 inhibitor failed to demonstrate any benefit, but I think that there are other agents that are being explored, so there are newer targets, newer agents, ADCs, bispecifics that could potentially change the field in the future. Brittany Harvey: Yes, we will look forward to the data to address these unanswered questions and new agents and inform future guideline updates. So, I would like to thank you both for all of your work to review the evidence here and update this important guideline, and for your time today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/gastrointestinal-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore talks with Prof Michael Millward, Foundation Professor of Clinical Cancer Research at the University of Western Australia and the oncology Medical Director at Linear Clinical Research in Perth. They discuss Prof Millward's extensive background in clinical and research interests in lung cancer and melanoma, the evolution of clinical trials, and the future of medical oncology, touching on molecular diagnostics, liquid biopsies, and early phase drug development. Millward also shares personal anecdotes and practical advice for young oncologists seeking to integrate clinical research into their careers.(00:00) Introduction and Acknowledgements(00:31) Guest Introduction: Professor Michael Millward(01:49) Early Career and Training(05:23) Specialisation in Oncology(08:15) Advancements in Molecular Oncology(15:03) Building a Phase One Unit(21:37) Mentorship and Future of Clinical Trials(28:23) Future of Lung Cancer Treatment(30:33) Closing Remarks and Final Thoughts 

Welcome to Episode 79  of the Wed.Co Podcast. Today, Toga sits down with Jay Geering for Round 2. In this episode, we explore the critical role of mindset in scaling a wedding industry business, alongside practical strategies for growth, client engagement, and personal development. Whether you're feeling stuck or ready to elevate, this conversation offers actionable insights to transform your approach. Takeaways The importance of mindset as the foundation for success (00:57, 4:04, 8:50) How internal beliefs, identities, and emotional blocks impact business growth (01:16, 2:53, 8:03) The value of coaching, outsourcing, and investing in personal development (⁠30:13⁠, ⁠24:32⁠) Strategies for effective lead follow-up and client communication (52:03, 57:23) The psychology of sales and understanding client buying cycles (48:51, 50:01) Building authentic relationships with clients through leadership and trust (62:02, 68:43) Goal setting, visualization, and future pacing for long-term fulfillment (39:32, 41:50) The science of neuroplasticity and creating new habits (45:50, 46:20) How to handle rejection and the power of follow-up (56:53, 57:23) Tips for defining ideal clients and creating marketing messages that resonate (61:32, 62:02) The importance of clarity, internal alignment, and strategic planning (42:17, 43:13) The daily habits and consistency required to sustain growth (18:35, 20:12) If you want to hear more from Jay Geering you can get more info on Instagram at ⁠Jay Geering⁠ Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals.   Stay connected with us on Instagram at ⁠https://www.instagram.com/wed.copodcast⁠ and watch all your favorite wedding professionals on our YouTube channel ⁠https://www.youtube.com/@Wed.CoPodcast⁠ Catch our episodes on major podcast platforms like ⁠Apple⁠, ⁠Spotify⁠, and ⁠Youtube,⁠ all under WedCo Podcast.   For all of your Wedding Photography / Videography needs head over to ⁠https://www.instagram.com/the_tognazzinis/⁠ or our website at ⁠https://thetognazzinis.com.au/⁠ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the  mesmerising and ever-changing landscape of weddings.   Toga    

Welcome to Episode 78 of the Wed.Co Podcast. Today, Toga sits down with Nat from Under the Arbor and Celebration Studio for a chat about her new business Celebration Studio. filmed at Pod Byron Summary In this episode of the Wedco podcast, host Toga welcomes back Nat, the founder of Under the Arbor, to discuss her journey in the wedding industry, the growth of her business, and her new venture, Celebration Studio. They explore themes of team dynamics, investing in people, and the importance of mentorship. Nat shares insights on managing a young team, defining success, and the challenges of work-life balance. The conversation also highlights the upcoming Beyond Booked Out workshop aimed at supporting wedding professionals in achieving sustainable growth and avoiding burnout. Takeaways Investing in people is crucial for business growth. Mentorship can significantly impact team dynamics. Creating a supportive team culture enhances performance. Work-life balance is essential for long-term success. Feedback from workshops is vital for improvement. Sustainability in the wedding industry is a growing concern. Networking and education are key for wedding professionals. Setting clear goals helps in achieving work-life balance. Continuous learning is important for personal and professional growth. Building strong relationships in the industry fosters collaboration. If you want to hear more from Nat you can get more info at    ⁠https://www.underthearbour.com.au ⁠⁠https://www.thecelebration.studio⁠ and on Instagram at ⁠https://www.instagram.com/wearethecelebrationstudio/⁠ Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals.   Stay connected with us on Instagram at ⁠https://www.instagram.com/wed.copodcast⁠ and watch all your favorite wedding professionals on our YouTube channel ⁠https://www.youtube.com/@Wed.CoPodcast⁠ Catch our episodes on major podcast platforms like ⁠Apple⁠, ⁠Spotify⁠, and ⁠Youtube,⁠ all under WedCo Podcast.   For all of your Wedding Photography / Videography needs head over to ⁠https://www.instagram.com/the_tognazzinis/⁠ or our website at ⁠https://thetognazzinis.com.au/⁠ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the  mesmerising and ever-changing landscape of weddings.   Toga    

Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Dr. Megan Sanders, the Chief Executive Officer of TOGA. They discuss Megan's journey from working in vaccine formulation to earning a PhD in immunology, working in clinical trials, and eventually leading TOGA. They explore the challenges and achievements of TOGA, the importance of multidisciplinary engagement in lung cancer treatment, and the organisation's strategic plan for strengthening research and membership engagement. The conversation touches on the potential of clinical quality registries to improve patient care and highlights the ongoing effort to address the gaps in funding and equitable care for lung cancer patients.(00:00) Introduction and Acknowledgements(00:36) Meet Dr. Megan Sanders: From Science to Leadership(01:21) Journey from Academia to Clinical Trials(05:27) Challenges and Rewards in Clinical Trials(09:24) TOGA's Achievements and Multidisciplinary Approach(26:39) Future Directions and Strategic Plans(36:55) Conclusion and Final Thoughts Links: Dr Megan Sanders https://www.linkedin.com/in/megan-sanders-20130156/TOGA Strategic Plan: https://thoraciconcology.org.au/news/toga/toga-launches-new-strategic-plan-2025-2028-to-advance-thoracic-cancer-research-in-australasia/TOGA ASM 2026:https://thoraciconcology.org.au/events/toga-annual-scientific-meeting-2026/

Antonio Settembre"La toga spezzata"Viaggio nel Processo Penale e nella Riforma che cambia la Magistratura.Distribuzione: www.amazon.itUn viaggio chiaro e coinvolgente dentro i meccanismi del processo penale, per orientarsi tra regole, ruoli e recenti riforme. Scopri cosa cambia con la riforma della separazione dellecarriere e perché riguarda da vicino anche te.Durante la sua carriera, l'autore ha trattato – come relatore ed estensore della sentenza – numerosi processi importanti, tra cui la strage dei Georgofili a Firenze, del 1993, e tutte quellecollegate di via Palestro a Milano, di via Fauro a Roma, di San Giovanni in Laterano e di San Giorgio al Velabro, anch'esse commesse a Roma, oltre, ovviamente, a numerosissime altrevicende giudiziarie, soprattutto in materia fallimentare. Oggi ci racconta, attraverso la sua esperienza professionale, la complessa macchina della giurisdizione italiana, civile e penale, per arrivare a sviscerare il processo penale e comprendere i punti più cruciali del Referendum di giustizia del 22 e 23 marzo 2026."Il processo penale italiano è una delle costruzioni giuridiche più sconosciute al cittadino medio. Sebbene la sua rilevanza sociale e il suo impatto sulla vita delle persone siano estremamente significativi, la conoscenza dei meccanismi che presiedono al funzionamento del processo risulta appannaggio di pochi; in pratica, dei soli operatori giuridici - magistrati e avvocati penalisti - impegnati nella gestione dei processi.L'ambizione di questo scritto è, innanzitutto, quella di fornire, ai non addetti ai lavori, nella maniera più semplice e obbiettiva possibile, le cognizioni minime atte a comprendere qual è la struttura del procedimento penale, come nasce e come evolve e quali sono i soggetti che si muovono nell'ambito dello stesso. Ciò verrà fatto con l'utilizzo di un linguaggio non tecnico, o minimamente tecnico, per estendere al massimo la platea dei possibili fruitori di questo scritto.Non è dubitabile che la conoscenza del sistema giudiziario (riferita, quantomeno, al sistema penale) non solo aiuterà a comprendere l'evoluzione di moltissime vicende giudiziarie dell'attualità, ma può contribuire alla formazione di un giudizio più consapevole sulle infinite questioni che agitano il mondo della giustizia, squassato, come pochi altri, dalle polemiche e dalla disinformazione."Antonio Settembre nasce a Salerno nel 1955. Ha iniziato a lavorare in magistratura come pretore a Cagliari nel 1986. Successivamente, da 1991 al 1996, ha lavorato come sostitutoprocuratore a Lucca, poi giudice a Firenze dal 1996 al 2012. Fino al 2021 è stato consigliere della Corte suprema di cassazione e fino alla pensione nel 2025, Presidente di sezione della Corte d'appello di Firenze.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/il-posto-delle-parole--1487855/support.IL POSTO DELLE PAROLEascoltare fa pensarehttps://ilpostodelleparole.it/

Solve crimes with the great detective in "Sherlock Holmes Short Stories." Featuring classic tales by Arthur Conan Doyle, this podcast brings you the brilliant deductions and thrilling adventures of Sherlock Holmes and Dr. Watson. Whether you're a longtime fan or new to the world of Holmes, these timeless mysteries will keep you captivated.

Welcome to Episode 77  of the Wed.Co Podcast. Today, Toga sits down with Teddy from @marriedbyateddy for a chat about his journey in the wedding industry as a celebrant and the importance of inclusivity in ceremonies. This episode was filmed at Pod Byron Summary In this episode of the Wedco Podcast, host Toga speaks with Teddy, a celebrant who shares his journey into the wedding industry and the importance of inclusivity in ceremonies. Teddy discusses his background in corporate sales and marketing, and how it has shaped his approach to celebrancy. He emphasizes the need for inclusivity in language and practices, and how small changes can create a welcoming environment for all guests. The conversation also touches on the use of technology to enhance inclusivity, the significance of building relationships within the wedding industry, and the importance of nurturing client relationships for long-term success. Takeaways Teddy has been a celebrant for nearly 12 months, leveraging his corporate background. Inclusivity in weddings is about expanding the situation for all identities. Small changes in language can create a welcoming environment for all guests. Teddy emphasizes the importance of holding space during ceremonies. Using technology can help identify and eliminate gendered language in scripts. Building relationships with other vendors is crucial for success in the wedding industry. Nurturing client relationships can lead to better referrals and a more personalized experience. Inclusivity is not just about language; it's about creating a safe space for everyone. Teddy offers an inclusivity guide to help vendors improve their practices. Community over competition is essential in the wedding industry.     If you want to hear more from Teddy you can get more info at his website and on Instagram Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals.   Stay connected with us on Instagram at https://www.instagram.com/wed.copodcast and watch all your favorite wedding professionals on our YouTube channel https://www.youtube.com/@Wed.CoPodcast Catch our episodes on major podcast platforms like Apple, Spotify, and Youtube, all under WedCo Podcast.   For all of your Wedding Photography / Videography needs head over to https://www.instagram.com/the_tognazzinis/ or our website at https://thetognazzinis.com.au/ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the  mesmerising and ever-changing landscape of weddings.   Steve Toga

Crônicas da Cidade - 16/01

What if a Quirkless kid could change not just himself, but an entire system built on power? We go all-in on My Hero Academia, charting a ten-year run that evolves from entrance exams and classroom duels into a hard look at institutions, ideals, and the price of becoming a symbol. We start with the spark—Deku's worthiness, All Might's mask, and why that first “You can be a hero” still hits—then follow the fuse through the sports festival, Stain's critique, and the moment admiration turns into intention.The middle chapters raise the stakes and the questions. Overhaul's use of Eri, Lemillion's sacrifice, and Endeavor's Prominence Burn test what heroism looks like when smiling isn't enough. The war arc blows the doors off: Mirko's charge, Hawks and Twice's irreconcilable truths, Dabi's televised confession, and a society that stops believing. Deku's vigilante stretch becomes a mirror—strategy sharpened by exhaustion, compassion strained by isolation—until Class 1A drags him back, not with punches, but with proof that heroes stand together or not at all.We dig into late-game pivots and payoffs. Star and Stripe's last move, the UA traitor reveal, and Toga's final choice reveal the engine beneath the spectacle: people shaped by neglect, incentives, and myths. The films get their due—Two Heroes' mentorship, Heroes Rising's “what if the torch moved,” World Heroes' Mission's global stakes, and a “You're Next” pretender who misunderstands what makes a symbol real. Finally, we unpack the ending: Deku's decision to give power away, the difference between peace and hope, and why a single stranger taking a child's hand might be the bravest image in the series.If this journey rekindled your Plus Ultra, tap follow, share with a friend who loves a good transformation arc, and drop a review with your top three MHA fights. Your support helps more curious fans find the show.Text us for feedback and recommendations for future episodes!Support the showWe thank everyone for listening to our podcast! We hope to grow even bigger to make great things happen, such as new equipment for higher-quality podcasts, a merch store & more! If you're interested in supporting us, giving us feedback and staying in the loop with updates, then follow our ZONE Social Media Portal to access our website, our Discord server, our Patreon page, and other social media platforms! DISCLAIMER: The thoughts and opinions shared within are those of the speaker. We encourage everyone to do their own research and to experience the content mentioned at your own volition. We try not to reveal spoilers to those who are not up to speed, but in case some slips out, please be sure to check out the source material before you continue listening!Stay nerdy and stay faithful,- J.B.Subscribe to "Content for Creators" on YouTube to listen to some of the music used for these episodes!

Dimes and Judas discuss the civilizational consequences of pirate moms making diet coke chicken and Trump's brazen abduction of Venezuela's president Nicolas Maduro. After exploring the globally cataclysmic Exothermic Core-Mantle Decoupling – Dzhanibekov Oscillation (ECDO) theory, they begin their review of the book “The Dawn of Canadian History” by Stephen Leacock. This short analysis from the early 20th century gives an overview of the varying Aboriginal tribes found in Canada, what level of societal advancement they were at, and what could be expected from forging relationships with them. Lastly, on this edition of The Copepranos Society, we present the audio recording of the Canada Banquet from Millenniyule 2025 featuring Dimes, John Carter, Fortissax, Course of Empire, and more! Timestamps: 02:29 – The Dissident Right is Just Guys Bein Dudes 05:35 – Eyepatch Bigmom makes Diet Coke Chicken (Good Ending) 10:42 – What is Better than Rice and Salt? 13:43 – Danny Trejo Excited About Meeting a Guy Who Works at the Ice Cream Factory 15:38 – A Good Crushed Family Scenario 18:05 – Media Admits Children Were Killed by Covid Vaccine to Defeat the Right 23:38 – A Lengthy Discussion of Nicolas Maduro's Abduction 1:15:44 – Explaining Exothermic Core-Mantle Decoupling – Dzhanibekov Oscillation 1:25:22 – Pregnant Dimes Missed Positron Day in Science Class 1:27:28 – Show News: New Magazine Launch, April Event Earlybird Tickets 1:31:53 – “The Dawn of Canadian History” Discussion Begins 2:09:14 – Millenniyule 2025 Canada Banquet Begins

酒飲みソングから始まる年末 / ドサクサの12月 / TOGAの靴下大人買いした / 2年で大成長を遂げたRieka / アメ(犬)がゴトゴト言ってます / ホエイを無駄にしない / おしゃれ栄養ヨーグルト / 写経おもろい / ご縁に執着しない / 十牛図という茶碗 / 寺で婚活 / 貴重な話を聞けるようになった / 仏教と哲学は人類の初期設備 / 年末はみんな食べるもの似ちゃうよね / ラジオ推し活に忙しい / 雑ディレクターのイケる / 大掃除するなら窓枠一択 / 風通しの良い一年に / お掃除マスターRieka / 人生初の靴洗い / 靴洗いブラシをどこに置くのか / 年末の大雑談 / エイリアンRiekaトラウマ / 良いお年を～

La reforma judicial de 2024 marca una nueva etapa para la justicia en México. Las y los jueces electos por voto popular están ya en funciones

It's our year-in-review fashion and culture edition. I'm joined by new Ground Pass contributor Kaya Courtside to break down the exhibition season and what it's really like covering tennis behind the scenes, from UTS Finals in London to the chaos and charm of these off-season events. Then I hand out my 2025 tennis style “awards,” from best dressed and outfit of the year to the meme moments that took over our feeds. Plus, quick tennis news: the WTA's Mercedes-Benz era begins in 2026, Garbiñe Muguruza joins Madrid's leadership team, Serena's testing-pool headline sparks speculation, and Next Gen is around the corner. 00:00 Introduction to the Year in Review03:12 Introducing Kaya Courtside and UTS Finals30:10 Exhibition Season and Upcoming Events31:03 Fashion and Style Awards of 202536:11 Outfit of the Year and Brand Partnerships41:58 Cultural Moments and Player Highlights45:29 Tennis Photos and Memes of the Year51:31 Most Stylish Tournament and Personality of the Year58:52 WTA News and Future Predictions01:04:44 Upcoming Projects and Wrap-UpLinks:- GP Exhibition Deep Dive Episode - https://youtu.be/fjuxg3dzIXs?si=raOH2B8XOMWO7wrD - The Real Challenger Documentary - https://youtu.be/fjuxg3dzIXs?si=raOH2B8XOMWO7wrD - Off Season Instagram - https://www.instagram.com/offseasontv?igsh=MWJhaHZ4ano4NWlpeQ%3D%3D&utm_source=qr - Off Season Tiktok - We have Merch!!! Ground Pass Shop - https://www.groundpasspodcast.com/ground-pass-shop

En este episodio ponemos la lupa en la decisión judicial que dejó en libertad a cuatro presuntos cómplices de Raúl Rocha Cantú, pese a la acusación de la FGR, y las reacciones que desató. También hablamos del nuevo discurso de Donald Trump, quien califica al fentanilo como “arma de destrucción masiva”, del caos político que llegó hasta los jalones de cabello en una sesión legislativa y de la cruda realidad laboral: 13.7 millones de personas en México se quedaron sin aguinaldo. Cerramos con una noticia que sacudió al mundo del cine: el reporte de la muerte del director Rob Reiner y su esposa, encontrados sin vida en su domicilio. Un episodio cargado de polémica, política y sacudidas sociales. Dale play y... ¡Entérate! Un podcast de EL UNIVERSAL Hosted on Acast. See acast.com/privacy for more information.

Welcome to Episode 76 of the Wed.Co Podcast. Today, Toga sits down with Emma from Emma Wise Photography for a chat about her 15-year journey in the wedding industry, the rise of editorial wedding photography, and how her new AI-powered platform Wedlii is set to transform the way couples plan weddings, filmed at Pod Byron Studio. Summary In this episode, Emma shares her story of building a successful wedding photography business over more than 15 years. From her early days in Melbourne to rebuilding her entire brand after relocating to Byron Bay. She discusses how her background in fashion design and her experience working with top designers and photographers in London shaped her signature editorial style long before it became a trend. Emma also dives deep into the evolving role of AI in the creative industry. Rather than fearing it, she explains how AI can empower photographers, streamline workflows, and elevate artistic direction. She believes human creativity and story will become even more valued as AI becomes more mainstream. The conversation also highlights the creation of Wedlii, an AI-supported wedding planning platform designed to reduce stress for couples, simplify communication, and create a more connected, human-centric approach to planning. Wedlii offers curated vendor recommendations, planning tools, messaging systems, wellness resources, and a dedicated vendor portal to make collaboration easier. Emma shares how Wedlii will support not just couples, but also vendors and venues by improving communication, reducing overwhelm, and fostering a more collaborative wedding community. With its launch planned for just after Christmas, Wedlii is positioned to become a powerful new tool for brides, grooms, and wedding professionals alike. Takeaways Emma's fashion background heavily influenced her signature editorial wedding photography style. Rebuilding her business in Byron Bay gave her the opportunity to refine her creative direction. AI is not replacing creatives — it's a tool that can elevate artistry and streamline workflow. Wedlii is an AI-supported wedding planning platform designed to reduce stress and bring everything into one place for couples. The platform provides curated vendor recommendations rather than overloaded directories. Wedlii includes a vendor and venue portal to streamline communication and collaboration. Wellness support, including nutrition and stress management tools, is integrated into the platform to help couples throughout the planning process. Wedding planners remain essential — Wedlii is designed to complement, not replace, human experts. Wedlii aims to strengthen community and connection across the wedding industry. If you want to sign up for Wedlii email Emma at Hello@Wedlii.com.au or head to https://www.wedlii.com.au/ If you want to hear more from Emma at Emma Wise Photography, you can get more info at Website: https://www.emmawisephotography.com Instagram: https://www.instagram.com/emmawisephotography Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals. Stay connected with us on Instagram at https://www.instagram.com/wed.copodcast and watch all your favourite wedding professionals on our YouTube channel: https://www.youtube.com/@Wed.CoPodcast Catch our episodes on major podcast platforms like Apple, Spotify, and YouTube — all under WedCo Podcast. For all of your Wedding Photography / Videography needs, head over to https://www.instagram.com/the_tognazzinis/ or our website at https://thetognazzinis.com.au/ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the mesmerising and ever-changing landscape of weddings. Toga

In this episode of 'Conversations in Lung Cancer Research,' host Dr. Rebecca Tay and fellow oncologists A/Prof Surein Arulananda and Dr. Dasantha Jayamanne (DJ) delve into the latest advances in small cell lung cancer treatment.They explore new first-line treatments, including checkpoint inhibitors and emerging novel agents like lurbinectedin and tarlatamab, highlighting their mechanisms, survival benefits, and toxicity management. The panel also discusses the evolving role of radiotherapy and future directions involving precision medicine and biomarkers. This comprehensive discussion aims to inform clinicians and healthcare professionals about the promising advancements reshaping the small cell lung cancer treatment landscape.This episode is sponsored by Roche.TOGA's SCLC Masterclass will take place 20 March 2026, at Novotel on Collins, MelbourneAn advanced workshop covering evolving standards of care and new therapies in SCLC.Early bird tickets available until 16 Feb 2026 > https://thoraciconcology.org.au/events/masterclass-small-cell-lung-cancer/RESOURCES AND LINKS:CREST trial https://pmc.ncbi.nlm.nih.gov/articles/PMC3058352/Caspian Study https://www.sciencedirect.com/science/article/pii/S1525730425001640CHEST RT https://trog.com.au/trials/trog-20-01-chest-rt/DeLLphi-303 https://www.annalsofoncology.org/article/S0923-7534(25)04288-7/fulltextIMforte https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.8006Japan study PCI vs MRIhttps://pubmed.ncbi.nlm.nih.gov/28343976/TIMESTAMPS:(00:00) Introduction and Acknowledgements(00:36) Overview of Small Cell Lung Cancer(02:03) Current First-Line Treatments(06:59) Radiotherapy in Small Cell Lung Cancer(11:36) New Developments in Maintenance and Second-Line Treatments(15:35) Exciting New Therapies and Future Directions(24:01) Radiotherapy and Immune Engaging Therapies(32:53) Conclusion and Future EventsKEYWORDS: SCLC, ES-SCLC, Small Cell Lung Cancer, Early Stage Small Cell Lung Cancer

Welcome to Episode 75 of the Wed.Co Podcast. Today, Toga sits down with David from Wedflow for a chat about the role of AI in the wedding industry and how he is implanting it across Wedflow and his two other Wedding Photo / Video Studios. In this episode of the WedCo Podcast, host Toga sits down with David from Wedflow to discuss the evolution of the wedding industry and the role of technology in transforming wedding planning and photography. They explore the challenges faced by wedding vendors, the importance of adapting to technological advancements, and the launch of Wedflow, an AI-driven tool designed to streamline communication and workflow for wedding professionals. The conversation delves into personal experiences, industry insights, and the future of AI in weddings. Takeaways "Commitment to running ads during tough times set us up for success post-COVID." "Automate, delegate, and eliminate to focus on growth and creativity." "AI tools like Wedflow save time and enhance service quality for wedding vendors." "Staying updated with industry trends is crucial for long-term success." "Outsourcing tasks can prevent burnout and improve work-life balance." "Wedflow's AI-driven email management is a game-changer for wedding professionals." "Embracing technology is essential to remain competitive in the wedding industry." "The wedding industry is ripe for innovation and technological advancement." "AI can help wedding vendors focus more on creativity and client experience." "The future of weddings involves integrating AI to enhance efficiency and service." If you want to hear more from David you can get more info at WedFlow and on Instagram at @wedflow.app Your support enables us to bring more enriching conversations and insights to both engaged couples and wedding professionals.   Stay connected with us on Instagram at https://www.instagram.com/wed.copodcast and watch all your favorite wedding professionals on our YouTube channel https://www.youtube.com/@Wed.CoPodcast Catch our episodes on major podcast platforms like Apple, Spotify, and Youtube, all under WedCo Podcast.   For all of your Wedding Photography / Videography needs head over to https://www.instagram.com/the_tognazzinis/ or our website at https://thetognazzinis.com.au/ Join us for our next episode on the Wed.Co Podcast, where we continue to explore the  mesmerising and ever-changing landscape of weddings.   Toga

This episode was presented by UJA. Support UJA's work at UJA.orgSubscribe to Inside Call me Back: inside.arkmedia.org/?utm_source=shownotes&utm_medium=podcast&utm_campaign=insideGift a subscription of Inside Call me Back: inside.arkmedia.org/giftsListen to What's Your Number: lnk.to/GsOESPSubscribe to Amit Segal's newsletter ‘It's Noon in Israel':arkmedia.org/amitsegal/Watch Call me Back on YouTube: youtube.com/@CallMeBackPodcastCheck out Ark Media's other podcasts: For Heaven's Sake: https://lnk.to/rfGlrA‘What's Your Number?': https://lnk.to/rfGlrAFor sponsorship inquiries, please contact: callmeback@arkmedia.orgTo contact us, sign up for updates, and access transcripts, visit: arkmedia.org/Ark Media on Instagram: instagram.com/arkmediaorgDan on X: x.com/dansenorDan on Instagram: instagram.com/dansenorTo order Dan Senor & Saul Singer's book, The Genius of Israel: tinyurl.com/bdeyjsdnToday's Episode: We are less than a week away from the beginning of Hanukkah. Keeping with recent Call me Back tradition, Dan was joined by Rachel Goldberg-Polin to discuss the timeless meaning of the Hanukkah story. What does it say about the conflict Jews face today? Can the few really defeat the many? And why are Jews so obsessed with counting?CREDITS:ILAN BENATAR - Producer & EditorADAAM JAMES LEVIN-AREDDY - Executive ProducerBRITTANY COHEN - Production ManagerMARTIN HUERGO - Sound EditorMARIANGELES BURGOS AND PATTRICIO SPADAVECCIA - Additional EditingMAYA RACKOFF - Associate ProducerGABE SILVERSTEIN - Community ManagementYUVAL SEMO - Music Composer

We are less than a week away from the beginning of Hanukkah. Keeping with recent Call me Back tradition, Dan is joined by Rachel Goldberg-Polin to discuss the timeless meaning of the Hanukkah story. What does it say about the conflict Jews face today? Can the few really defeat the many? And why are Jews […]

Samfylkingin í Reykjavík stendur á krossgötum. Hún þarf að velja sér leiðtoga í höfuðborginni í fyrsta skipti í nærri tuttugu ár. Forsætisráðherra vill halda þar völdum og er sögð vera á höttunum eftir nýjum oddvita. Það bar til í liðinni viku, undan Senegalströndum, að ráðist var á tyrkneska olíuskipið Mersin, líklega með sprengjudrónum. Skipið er í eigu tyrknesku útgerðarinnar Besiktas shipping en siglir undir fána Panama - og er talið tilheyra hinum svokallaða skuggaflota Rússa. Úkraínumenn hafa ekki gengist við árásinni en árásum af þessu tagi hefur fjölgað og þær eru taldar á gráu svæði. Á miðvikudaginn (10. desember) tekur bann við samfélagsmiðlanotkun barna undir sextán ára gildi í Ástralíu og varðar háum sektum ef fyrirtæki ganga ekki fram í að koma í veg fyrir að ungmenni komist á miðlana.

If movies like Animal House, Legally Blonde, and The House Bunny shaped your Greek life dreams… brace yourself. Greek life isn’t what Hollywood promises.See omnystudio.com/listener for privacy information.

If movies like Animal House, Legally Blonde, and The House Bunny shaped your Greek life dreams… brace yourself. Greek life isn’t what Hollywood promises.See omnystudio.com/listener for privacy information.

Nur ein Anno mit Toga? Wir diskutieren die historische Korrektheit von Anno 117: Pax Romana mit Micha, der Archäologin Michaela Zietlow und Strategie-Experten Gaius. Logistik, Kultur und das finale GameStar-Urteil!

El equipo de La Trinchera con Miguel Ángel Pérez, Rebeca Argudo y Percival Manglano a la cabeza repasan el bochorno del fiscal general en el juicio

In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC), including:Brief overview of BTC and GEAApproved HER2-directed therapies for BTC and GEA and their mechanisms of actionEfficacy and toxicities of the approved agents and optimal management strategiesKey ongoing trials of HER2-directed therapies in BTC and GEAChallenges faced by healthcare professionals in the management of patients with BTC and/or GEA PresentersAmit Mahipal, MD, MPHDirector, Gastrointestinal Medical Oncology ProgramRuth and Donald Goodman Endowed Chair in GI OncologyProfessor of Medicine, Senior Attending PhysicianUniversity Hospitals Siedman Cancer CenterCase Comprehensive Cancer CenterCase Western Reserve UniversityCleveland, OhioShubham Pant, MDProfessorDepartment of Gastrointestinal (GI) Medical OncologyDepartment of Investigational Cancer TherapeuticsDirector of Clinical ResearchAssociate Director for Early Phase Drug DevelopmentSheikh Ahmed Bin Zayed Al Nahyan CenterMD Anderson Cancer CenterHouston, TexasLink to full program:https://bit.ly/3KL2ank Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bogi Ágústsson og Þórunn Elísabet Bogadóttir ræddu fundahöld evrópskra leiðtoga í Kaupmannahöfn um fjölþáttaógnina frá Rússum. Leiðtogar Evrópusambandsins þinguðu í gær og í dag bætast fleiri evrópskir leiðtogar í hópinn, þar á meðal Kristrún Frostadóttir forsætisráðherra Íslands. Þá var einnig rætt um úrslit kosninga í Moldóvu þar sem PAS-flokkurinn (Aðgerðir og samstaða), fékk meirihluta þingsæta. PAS vill náið samstarf við Vesturlönd og inngöngu í Evrópusambandið.

We're wrapping up 1 & 2 Peter with quizzes written by our listeners!If you want MORE drinking and bible-ing, including bonus episodes, interviews with experts, fun mini series', and more, consider becoming a ‘parishioner' at Patreon.com/DrunkBibleStudyOur theme music is Book Club by Josh and Anand.

Put on your best toga and come party with the variants as we review Annabelle's Trust Me You'll Like It - Animal House!! TOGA, TOGA, TOGAPlease leave us a 5 star review on your podcast platform, drop us a follow on the socials, consider joining the Patreon, & share with your friends & family! Thank you for listening & thank you for all the support! Links for all of our stuff can be found here: https://linktr.ee/VariantVendettaYou can find our good friend's Podcasts here:https://www.abingerspodcast.com/https://linktr.ee/goingmerrypod

Paella, kuskus, citronové špízy s rýží nebo třeba saké, gin a kokosový sorbet. Konec prázdnin v Paříži už tradičně patří Mezinárodní gastronomické vesničce. Kuchyně z různých koutů světa se letos na nábřeží pod Eiffelovou věží představila už po sedmé. Tentokrát lidé mohli ochutnat vybraná jídla z Kambodže, Toga nebo Thajska.

Paella, kuskus, citronové špízy s rýží nebo třeba saké, gin a kokosový sorbet. Konec prázdnin v Paříži už tradičně patří Mezinárodní gastronomické vesničce. Kuchyně z různých koutů světa se letos na nábřeží pod Eiffelovou věží představila už po sedmé. Tentokrát lidé mohli ochutnat vybraná jídla z Kambodže, Toga nebo Thajska.Všechny díly podcastu Zápisník zahraničních zpravodajů můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

When I first connected with Jason Trew (callsign: TOGA), I knew this conversation would challenge some assumptions about where design thinking belongs. Jason is an Air Force fighter pilot and strategy leader turned professor. What emerged from our conversation wasn't just another story about design thinking adoption, but a deeper exploration of what he sees happening when we distinguish between capital-D Design Thinking and lowercase-d design thinking, and why that distinction matters for everyone trying to create meaningful change. Jason's journey from F-15 pilot to design educator reveals something crucial about how design thinking transforms not just what we do, but who we become as problem solvers. His work with thousands of Air Force officers, his deployment experiences in classified operations centers, and his current role (*at the time of recording) teaching at the Savannah College of Art and Design (SCAD) offer unique insights into how design thinking functions when the stakes are genuinely high. Listen to Learn About: What's the critical difference between capital-D Design Thinking and lowercase-d design thinking, and why does this distinction matter for practitioners? How can design thinking principles function effectively in highly structured, high-stakes environments where traditional approaches dominate? What role does psychological safety ("feeling safe, supported, and stretched in meaningful ways") play in enabling creative problem-solving? How do we balance the need for systematic approaches with the emergent, integrative nature of actual design work? When should leaders prioritize conditioning people into a "ready stance" versus teaching specific design methods? Our Guest Col Jason "TOGA" Trew (US Air Force, retired) represents a fascinating intersection of military leadership, academic rigor, and design practice. After graduating from the U.S. Air Force Academy and flying F-15s, Jason spent his final military decade revolutionizing how the Air Force approaches strategy education and leadership development. He earned a PhD in the history of technology, served as Dean and Vice Commandant of the Air Force Leadership School, and led design teams for Space Force education initiatives. Now a Professor of Design* Management at the Savannah College of Art and Design, Jason brings a unique perspective on what happens when design thinking meets organizational realities where failure isn't an option. (*At the time of recording.) Episode Highlights [02:10] Jason's journey from F-15 fighter pilot to design educator through strategy school and a PhD in technology history [03:30] Discovery of a book dedicated to Icarus as hero rather than cautionary tale, sparking interest in playfulness complementing practicality [04:20] How design thinking became curriculum at Air Force Leadership School serving 4,000 students annually [05:10] Jason's certification in Lego Serious Play for facilitating innovation sprints and strategic thinking workshops [07:20] The crucial distinction between capital-D Design Thinking and lowercase-d design thinking [09:00] Capital-D focuses on activities and checklists; lowercase-d develops embodied sensibility for knowing what to do next [11:40] Design thinking as conditioning people into a ready stance for handling surprise rather than teaching linear processes [13:00] Why Jason believes design thinking changes the people involved, with problem-solving as bonus rather than primary goal [14:40] How design thinking shifts perception to see multiple options beyond binary choices [15:30] Jason's approach to ambiguous assignments that allows students to surprise him with creative solutions [17:30] Learning design principles that avoid constraining student intelligence for the sake of rigid academic standards [18:50] Design thinking's spillover effects on leadership and education beyond formal design practice [22:40] Design thinking as fundamentally human activity connected to living well and building better communities [25:10] Coffee shop door story illustrating how design changes your eyes to see problems everywhere [26:40] Design as integrative discipline that's undisciplined in the best academic sense [28:40] Framework of design as expedient - practical, opportunistic, and contextual rather than optimal [30:00] Why expedient design requires ethical sensibility to guide this human superpower responsibly [32:30] Jason's faith that if we designed current systems, we can design something better [36:40] Deployment story of creating psychological safety in classified military operations center [38:30] Using Lego as thermoplastic polymer strategic thinking tool to overcome initial skepticism [39:00] Daily check-ins asking team members if they feel safe, supported, and stretched in meaningful ways [41:10] Danger of treating organizational roles as reality rather than abstractions of actual people [43:30] Failed redesign of Air Force Leadership School and lessons about empathy work threading through entire processes [46:00] Dawan's diagnostic questions about organizational readiness and past innovation attempts [48:30] Strategy for identifying key voices—influencers, critics, curmudgeons, and creators—in organizations [49:00] Power of storytelling as diagnostic tool and method for strategic thinking [50:40] Interest in story casting and narrative intelligence using physical artifacts like Lego Serious Play [51:00] Connection to UN Principles for Responsible Management Education and sustainable development goals [52:40] Jason's call for partnership in bringing design skills to local and systemic governance challenges Questions to Help You Go Deeper Learning What surprised you most about Jason's distinction between capital-D and lowercase-d design thinking, and how does this change your understanding of design thinking's role in organizations? Which aspects of Jason's "expedient" framework for design seem most valuable for your context — the practical, opportunistic, or contextual elements? How does Jason's experience with ambiguous assignments challenge your current approach to giving direction or defining success criteria? Leading Where in your organization would Jason's "safe, supported, and stretched in meaningful ways" framework create the most value for team performance? How might you help your team understand the difference between learning design methods and developing a design sensibility? What would success look like if you implemented Jason's approach to activating the full diversity already present in your team? Applying What's one small experiment you could run next week with leaving an assignment or challenge more open-ended? Which current organizational challenge could you address by focusing on conditioning people's "ready stance" rather than teaching them specific methods? How could you adapt Jason's storytelling diagnostic approach to better understand your team's readiness for change? Practicing How will you build the habit of distinguishing between roles/responsibilities (abstractions) and the full capabilities of people in those roles? What support or resources do you need to practice Jason's approach of setting conditions rather than controlling outcomes? Who could you partner with to practice the kind of empathy work Jason describes as threading through entire processes? Resources Books We Discussed Experiencing Design - Jason's top recommendation for understanding how activities yield experiences that yield ways of being in the world. Liedtka, Jeanne, Karen Hold, and Jessica Eldridge. Experiencing Design: The Innovator's Journey. Columbia Business School Publishing, 2021. Creating Wicked Students - About giving students practice with authority and ambiguity in classroom settings. Hanstedt, Paul. Creating Wicked Students: Designing Courses for a Complex World. Stylus Publishing, 2018. Tools We DiscussedLego Serious Play - Certification and facilitation methods for strategic thinking workshops The Archipelago of Design - Security professionals using design approaches.  COM-B Behavior Change Model - Capability, Opportunity, Motivation framework for behavior change. Michie, Susan, et al. "The Behaviour Change Wheel: A New Method for Characterising and Designing Behaviour Change Interventions." Implementation Science, vol. 6, no. 1, 2011, pp. 1-12. Keep LearningResearch Nigel Cross and Bryan Lawson's work on how designers think.  Cross, Nigel. Design Thinking: Understanding How Designers Think and Work. Academic Press, 2011. Lawson, Bryan. How Designers Think: The Design Process Demystified. 4th ed., Architectural Press, 2005. Explore participatory design and co-creation methodologies. Schuler, Douglas, and Aki Namioka, editors. Participatory Design: Principles and Practices. Lawrence Erlbaum Associates, 1993. Simonsen, Jesper, and Toni Robertson, editors. Routledge International Handbook of Participatory Design. Routledge, 2013. Investigate narrative intelligence Mateas, Michael, and Phoebe Sengers, editors. Narrative Intelligence. John Benjamins Publishing Company, 2003. (Advances in Consciousness Research, vol. 46) UN Principles for Responsible Management Education and sustainable development goals. United Nations Global Compact. Principles for Responsible Management Education. UN Global Compact Office, 2007. Deepen Your Learning Design Council UK + Systemic Design + Design in Government with Cat Drew — DT101 E78 Complements Jason's insights about bringing design to structured environments Cognitive Bias + Ethics + Dreaming the Future of Design with David Dylan Thomas — DT101 E112 Works with this episode to understand different approaches to design education Instructional Design + Adult Learning Experiences with Holly Owens — DT101 E134 Builds on Jason's themes about creating conditions for creative problem-solving

Los Poderes de la Nación atestiguaron el acto fundacional que da vida al nuevo Poder Judicial, en una ceremonia cargada de símbolos y retórica.

Massimo Giannini, editorialista e opinionista di Repubblica, racconta dal lunedì al venerdì il suo punto di vista sullo scenario politico e sulle notizie di attualità, italiane e internazionali. "Circo Massimo - Lo spettacolo della politica" lo puoi ascoltare sull'app di One Podcast, sull'app di Repubblica, e su tutte le principali piattaforme.See omnystudio.com/listener for privacy information.

North Star is on vacation this week, so we're rerunning some of our favourite episodes. This one originally aired May 4th, 2023 Canadians of a certain age will remember listening to the comedy duo of Wayne and Shuster on the radio—and, later, watching them on television from the 1950s well into the 1980s. The duo met in high school in Toronto's prewar Jewish neighbourhood around Harbord Collegiate, where they began writing and performing sketch comedy. After returning from entertaining the troops overseas during the Second World War, they joined the television era, with specials pulling in audiences of millions and worldwide syndication. Since their fathers' deaths, Wayne and Shuster's children have been campaigning to convince the CBC—which owns the broadcast rights to much of their parents' material—to air it for the first time in years for a new generation of Canadians to enjoy. These efforts have not been successful, so the families are taking a new strategy. They teamed up with Bygone Theatre, a theatre company in Toronto, to mount a live Wayne and Shuster stage show that opened at the University of Toronto's Hart House Theatre in May 25, 2023. It went on a national tour, too. Audiences got to see high-profile Canadian actors perform such classic W and S skits as “Rinse the Blood Off My Toga” and “A Shakespearean Baseball Game”. Michael and Brian Wayne joined The CJN Daily, along with Rosie Shuster and the producers of the play, Emily Dix and Conor Fitzgerald. **What we talked about
** When the City of Toronto named a lane after Wayne and Shuster, in The CJN
 For Canada's 150th anniversary in 2017, The CJN ran this profile of Wayne and Shuster
 Watch “Rinse the Blood off my Toga” on YouTube

 Credits Host and writer: Ellin Bessner (@ebessner)
 Production team: Zachary Kauffman (senior producer), Andrea Varsany (producer), Michael Fraiman (executive producer)
 Original Music: Dov Beck-Levine
 Current Music: Bret Higgins

 Support our show Subscribe to The CJN newsletter
 Donate to The CJN (+ get a charitable tax receipt) Subscribe to North Star (Not sure how? Click here)

The Paranormal Liberation War Arc of My Hero Academia represents a pivotal moment in the series, where the stakes are elevated significantly as the heroes confront formidable adversaries. Christian Ashley and Liz Clyde delve into the profound implications of this arc, exploring the multifaceted challenges faced by the characters as they grapple with the reality of war. They address the harrowing question of how one might vanquish an invincible foe, a theme that resonates throughout the narrative. Furthermore, the episode examines the psychological and emotional toll that warfare exacts upon both heroes and villains, underscoring the moral complexities inherent in their respective struggles. As the discussion unfolds, listeners are invited to reflect on the broader themes of heroism, sacrifice, and the quest for justice amidst chaos.The Paranormal Liberation War Arc in My Hero Academia unveils a tumultuous chapter in the ongoing saga of heroes versus villains, marked by significant character development and profound thematic explorations. This arc, sprawling across numerous episodes, delves deep into the fabric of hero society, presenting the audience with a stark portrayal of the consequences of war. Christian Ashley and Liz Clyde embark on an analytical journey, examining the intricacies of this arc, where the stakes have never been higher. They dissect the strategies employed by both the heroes and the villains, contemplating the implications of betrayal, sacrifice, and the quest for justice in a society riddled with moral ambiguity.The panelists highlight pivotal moments that define character arcs, particularly focusing on the emotional weight carried by characters such as Hawks, Twice, and Toga, whose narratives intertwine in a tragic yet compelling manner. The discussions reveal how the clash between the Paranormal Liberation Front and the heroes serves as a catalyst for personal growth and reflection among the protagonists, compelling them to confront their values and beliefs amidst chaos. Moreover, the episode underscores the arc's exploration of systemic flaws within hero society, challenging the audience to question the efficacy of the established order and the true meaning of justice.In conclusion, this episode of Systematic Geekology not only reviews the action-packed sequences of the arc but also delves into the philosophical underpinnings that drive the narrative forward. The conversation encapsulates the essence of what it means to be a hero in a world where the lines between good and evil are increasingly blurred, leaving listeners with much to ponder as they await the unfolding of future events in My Hero Academia.Takeaways: The Paranormal Liberation War Arc is a significant turning point for the series, showcasing the devastating impacts of war on both heroes and villains. This arc highlights the complexities of moral ambiguity, as the heroes face the repercussions of their actions while the villains reveal their motivations. The deaths of characters such as Twice and Midnight serve to elevate the stakes, profoundly affecting the emotional landscape of the narrative. The reveal of Dabi's true identity as Toya Todoroki adds depth to the familial themes within the series, complicating the hero-villain dichotomy. Deku's decision to separate himself from his friends illustrates the burdens of heroism and the sacrifices that come with it in the face of overwhelming odds. The arc serves as a critique of societal structures, questioning the efficacy and morality of the hero system in a world rife with prejudice and power imbalances. .We discuss all this and more in this one! Join in the conversation with us on Discord now!.Support our show on

Editorial: “Vaza Toga” expõe o “sistema chinês” de Moraes no TSE e no STF

Miquéias, Batata e Carcará se reúnem para o Fala Glauber News, apresentado por Erick Lobo. O programa vai ao ar de terça a quinta-feira, das 18h00 às 20h00.QUER FAZER PARTE DISSO? ENTÃO BOOORAAA. VEM COM A GENTE E INTERAJA NESSA TRANSMISSÃO AO VIVO!!!VIIIIIIIIBRA!!! CONHEÇA MAIS DOS NOSSOS PATROCINADORES:

Federico anima a ir mañana sábado a la movilización de jueces y Fiscales frente al Supremo. Con Vanessa Vallecillo y Sergio Heras.

About Forum Romanum, the NJCL Latin League, and strategies for teaching Roman history to beginning Latin students.Clint Hagen has been teaching Latin in the state of Texas for the past three decades. Having previously taught in the cities of Amarillo and Austin, he currently teaches at Fort Worth Country Day. He is the creator of Ecce Ambulatores!, an introductory-level Latin textbook, and The Toga and the Sword, a Roman history textbook for beginning Latin students. This past school year, Clint served as the inaugural commissioner of the NJCL Latin League, a year-long online trivia competition for middle school and high school Latin students. Forum Romanum Episode 18 VideoForum Romanum Episode 18 ScriptRequiescant in pace: Marcus Favonius (John Donohue) and Iulia Pauli (Amy High).CORRECTION: There were 24 episodes of this program.Recorded in June of 2025.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Quintilian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ is supported by a Bridge Initiative Grant from the Committee for the Promotion of Latin and Greek, a division of the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Classical Association of the Middle West and South⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Music: "Echo Canyon Instrumental" by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Clive Romney⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Comments or questions about this podcast may be directed to ryangsellers@gmail.com. Thanks for listening! If you're enjoying ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Quintilian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, please leave us a rating and/or a review on your favorite podcast distribution platform.

* Gobierno niega que Trump presione a Sheinbaum para extraditar a narcopolíticos* Mayo Zambada negocia acuerdo con la justicia de Estados Unidos* Morena busca eliminar el uso obligatorio de la toga en la Corte

Juan Jesús “Tito” Garza Onofre, Investigador del Instituto de investigaciones jurídicas de la UNAM

Welcome back to another episode of "The 151 Collective". Zack Mo and Collector review our weeks in collecting, talk pokemon market, revisit the weekly "Pokemon Highlight", and of course revisit our weekly rankings

Narrativas analisa os acontecimentos do Brasil e do mundo sob diferentes perspectivas.     Com apresentação de #MadeleineLacsko, o programa desmonta discursos, expõe fake news e discute os impactos das narrativas na sociedade.     Abordando temas como geopolítica, comunicação e mídia, traz uma visão aprofundada   e esclarecedora sobre o mundo atual.     Ao vivo de segunda a sexta-feira às 17h.   Apoie o jornalismo Vigilante: 10% de desconto para audiência do Narrativas  https://bit.ly/narrativasoa   Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

Har SVM-regeringen været en succes? Skal en ny regering række hen over midten? Kan Pia Olsen Dyhr blive finansminister i en rød/lilla regering? Og hvem er den blå statsministerkandidat, hvis det skulle ende med et blåt flertal? Hvad kan – og vil – Inger Støjberg og Mona Juul egentlig? Borgen Unplugged er taget på det politiske værtshus Toga i denne Påske Special og optager for første gang en live-udsendelse, hvor vi giver en status på Folketingets partier her lidt mere end halvvejs gennem valgperioden. Og der er nok at kigge på. Martin Flink stiller spørgsmålene, Anders Langballe og Jyllands-Postens politiske analytiker Niels Th. Dahl giver svarene.